As Delta Variant Surges, Medicomp Systems Cancels Participation in HIMSS21
WASHINGTON, July 30, 2021 /PRNewswire/ — Medicomp Systems, which makes medical data relevant, usable and actionable, today announced that it is canceling its participation in the HIMSS21 Global Health Conference & Exhibition, August 9-13, 2021, in Las Vegas. With new COVID-19 cases surging due to the Delta variant, company leaders made the decision based on their commitment to keeping staff safe from infection.
“Over the last several months, we have invested significant time and resources to prepare for what we hoped would be a very special HIMSS conference. Unfortunately, with the recent surge in COVID-19 cases due to the spread of the Delta variant, we have concluded that our attendance poses an unacceptable health risk for our staff and their families,” said David Lareau, CEO of Medicomp Systems.
Medicomp Systems had planned to offer HIMSS attendees a sneak peak of Holy Name’s internally developed EHR and emtelligent, plus share details of its new licensing partnership with CPSI to integrate Quippe Clinical Data Engine into CPSI’s acute and post-acute EHR platforms. Customers and partners are encouraged to reschedule meetings here.
About Medicomp Systems
Medicomp Systems is a leading provider of solutions that make data usable for connected care and better outcomes. In 1978, Medicomp pioneered the patented MEDCIN® Knowledge Engine to present relevant clinical concepts in less than a second for any of tens of thousands of diagnoses or patient presentations. For more than 40 years, Medicomp has worked with physicians from leading medical centers and institutions to create solutions that work seamlessly with any EHR to deliver diagnostically relevant and actionable information to clinicians at the point of care. The MEDCIN clinical engine powers the Medicomp Quippe suite of solutions and creates intuitive workflows that support – rather than disrupt – the way clinicians think and work. Medicomp’s solutions deliver proven clinical and financial ROI, including reduced documentation and coding costs, increased clinician productivity, improved outcomes, and appropriate reimbursement. With minimal time and financial investment, stakeholders can deploy the robust clinical engine to filter data from disparate sources and organize structured and unstructured data into relevant and usable information. With real-time access to patient- and problem-specific information, clinicians are empowered to deliver better care and outcomes. To learn more about how Medicomp solutions can benefit your organization, visit http://www.medicomp.com/.
View original content to download multimedia:https://www.prnewswire.com/news-releases/as-delta-variant-surges-medicomp-systems-cancels-participation-in-himss21-301344940.html
SOURCE Medicomp Systems
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.